Tags

Type your tag names separated by a space and hit enter

A timely update of global COVID-19 vaccine development.
Emerg Microbes Infect. 2020 Dec; 9(1):2379-2380.EM

Abstract

This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanced information of the global response and resources for COVID-19 vaccines under development featuring: 1) NGOs and the regulatory perspective, 2) the status of vaccine development efforts, and 3) panel discussions to present and discuss challenges. ISV is a non-profit scientific organization whose members work on all areas relevant to vaccines. ISV plans to host additional virtual symposia including regional meetings and incorporating other topics along with COVID-19 vaccines.

Authors+Show Affiliations

Department of Infectious Diseases, King's College London, London, UK.ProTherImmune, Lafayette, CA, USA. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33059515

Citation

Klavinskis, Linda S., et al. "A Timely Update of Global COVID-19 Vaccine Development." Emerging Microbes & Infections, vol. 9, no. 1, 2020, pp. 2379-2380.
Klavinskis LS, Liu MA, Lu S. A timely update of global COVID-19 vaccine development. Emerg Microbes Infect. 2020;9(1):2379-2380.
Klavinskis, L. S., Liu, M. A., & Lu, S. (2020). A timely update of global COVID-19 vaccine development. Emerging Microbes & Infections, 9(1), 2379-2380. https://doi.org/10.1080/22221751.2020.1838246
Klavinskis LS, Liu MA, Lu S. A Timely Update of Global COVID-19 Vaccine Development. Emerg Microbes Infect. 2020;9(1):2379-2380. PubMed PMID: 33059515.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A timely update of global COVID-19 vaccine development. AU - Klavinskis,Linda S, AU - Liu,Margaret A, AU - Lu,Shan, PY - 2020/10/17/pubmed PY - 2020/11/5/medline PY - 2020/10/16/entrez KW - COVID-19 KW - SARS-CoV-2 KW - international society for vaccines KW - vaccine SP - 2379 EP - 2380 JF - Emerging microbes & infections JO - Emerg Microbes Infect VL - 9 IS - 1 N2 - This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanced information of the global response and resources for COVID-19 vaccines under development featuring: 1) NGOs and the regulatory perspective, 2) the status of vaccine development efforts, and 3) panel discussions to present and discuss challenges. ISV is a non-profit scientific organization whose members work on all areas relevant to vaccines. ISV plans to host additional virtual symposia including regional meetings and incorporating other topics along with COVID-19 vaccines. SN - 2222-1751 UR - https://www.unboundmedicine.com/medline/citation/33059515/A_timely_update_of_global_COVID_19_vaccine_development_ L2 - https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1838246 DB - PRIME DP - Unbound Medicine ER -